Company

Neurovance, Inc.

Neurovance, Inc. is a Cambridge, Massachusetts clinical-stage neuroscience company developing EB-1020 SR for adult ADHD.

About

Founded in 2011 and based in Cambridge, Massachusetts, Neurovance, Inc. is a clinical-stage neuroscience company. It is developing EB-1020 SR for adults who suffer from ADHD. The company is listed at the Series A stage.

5Funding rounds

5Investors

Sign in to see more

Funding rounds, investors and people for this company come from licensed data. A free account shows the first rows of each section; an approved contribution opens every profile in full.

Sign in